Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1993-11-19
1995-01-10
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 3119
Patent
active
053807600
ABSTRACT:
Transdermal drug formulations containing a prostaglandin, optionally a lipophilic excipient, and a polyisobutylene pressure sensitive adhesive.
REFERENCES:
patent: 3069322 (1962-12-01), Bergstrom et al.
patent: 4103026 (1978-07-01), Carlson
patent: 4254145 (1981-03-01), Birnbaum et al.
patent: 4515810 (1985-05-01), Chow et al.
patent: 4594240 (1986-06-01), Kawata et al.
patent: 4707495 (1987-11-01), Rosenthale et al.
patent: 4889845 (1989-12-01), Ritter et al.
patent: 5219885 (1993-06-01), Frolich et al.
J. Org. Chem. 1974, 37, 2921.
J. Chromatography, 1991, 555, 73.
Braun Franz-Josef
Wendel Hanns
Griswold Gary L.
Kirn Walter N.
Minnesota Mining and Manufacturing Company
Peabody John
Reedich Douglas E.
LandOfFree
Transdermal prostaglandin composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transdermal prostaglandin composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal prostaglandin composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-850993